Mounjaro prices in 2026: what drives the cost and how to judge value

Why Mounjaro's price jumped in autumn 2025 — and where it sits now

The single biggest shift in UK private pricing came when Eli Lilly revised its list price from 1 September 2025. Across the dose range, that pushed the market upward: the highest 15mg strength moved from roughly £122 to around £330 per four-week pen at list level, and providers set their own margins above that. As widely reported at the time, lower doses increased by smaller amounts, so the gap between a starter month and a maintenance month became more pronounced.

Those figures are the backdrop, not a fixed rule. Private pharmacy prices change, and the doses actually prescribed vary between patients. What matters when you're looking at a monthly figure is which dose it refers to and (critically) what it includes beyond the medicine itself. You can find a fuller breakdown of how prices differ across the dose ladder on our Mounjaro price comparison page, and we track any further shifts on our Mounjaro price change page.

One practical question many people are asking right now is whether costs might fall again. We cover whether the price of Mounjaro drops in 2026 on its own page, including what we know about the factors that could drive a Mounjaro price decrease in 2026, from supply chain shifts to increased competition. The short answer is: possible, but not guaranteed.

What headline prices usually leave out

You've probably noticed some providers advertise a per-pen price in large type. That number is easy to find, and easy to misread. Before you assume two prices are comparable, it's worth asking what the quoted figure actually covers.

Consultation fees are sometimes charged separately, anywhere from £20 to more than £60 per session, depending on the service. Prescription fees are another variable: at some pharmacies they're bundled in; at others they appear on checkout. Delivery may be listed as free on the front page and then added at the last step. And aftercare (the clinical oversight between doses that determines whether a titration is appropriate) is simply absent from some services. If you're on a starting dose and need to move up, some providers charge for that review as a fresh consultation.

None of this is named or shamed: the point is that comparing headline prices for a prescription medicine without comparing what's included gives you incomplete information. Our tirzepatide injections cost page walks through exactly how to read a private pharmacy quote. A broader sense of how Mounjaro pricing works is on its own dedicated page if you want the longer view.

Where nume sits in this, and why we price the way we do

Honestly, you might feel slightly overwhelmed looking at the numbers right now. Weight management is already a personal and often frustrating topic, and being met with a wall of varying prices and small print doesn't help. So here is a straight answer about how we work.

At nume, one price covers everything: consultation, prescription, your treatment, next-working-day DPD delivery tracked to your door, and seven-day priority aftercare. There are no subscriptions and no auto-renewals. Before every repeat order, a real clinician (a GPhC-registered Independent Prescriber) reads your responses and approves continuity where it's clinically appropriate. We don't add a separate review fee for dose changes.

We are not the cheapest option on the market, and we set prices that way deliberately. The cost of running a GPhC-registered pharmacy with personal prescriber review on every order, same-day dispatch and included aftercare is higher than the cost of a bare-bones dispensing operation, and we don't think the difference is one you should have to guess at. Current treatment prices are shown clearly on our treatment page, no per-pen figures buried in small print, no discount codes, no flash sales. If you want to know more about our clinical team and the prescribers behind every decision, our clinical team page is there.

Why 'cheapest' is the wrong question for a prescription medicine

For almost any other product, price is a reasonable proxy for value. For a prescription-only medicine supplied through an unverified seller, it can be a warning sign.

The MHRA has issued multiple public warnings about counterfeit weight-loss pens sold online and through social media. Fake pens have been found to contain insulin rather than tirzepatide, with serious consequences. In enforcement activity through 2025, approximately 20 million doses of illegally traded weight-loss medicines (worth around £45 million) were seized, and the first known illicit UK manufacturing site producing counterfeit tirzepatide pens was uncovered in Northampton. The MHRA Yellow Card scheme allows anyone to report a suspect seller, and the GPhC pharmacy register lets you verify in seconds whether a pharmacy is legally operating. Our GPhC premises registration is 9012878, verifiable directly on the register.

A legitimate provider sourcing Mounjaro through the licensed UK supply chain, with genuine prescriber oversight, cannot offer prices far below market without cutting something. The right question is not which price is lowest but which service is clinically safe, properly regulated, and transparent about what you're getting. That's the decision worth making carefully. For a fuller picture of how much you might lose on tirzepatide and how clinical outcomes compare to cost, our tirzepatide results page sets the evidence in context.